Patent details

EP3110444 Title: COMBINATION THERAPY FOR CANCER

Basic Information

Publication number:
EP3110444
PCT Application Number:
US2015016529
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157086380
PCT Publication Number:
WO2015130540
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY FOR CANCER
French Title of Invention:
THÉRAPIE COMBINAISON POUR CANCER
German Title of Invention:
KOMBINATIONS THERAPIE FÜR KREBS
SPC Number:

Dates

Filing date:
19/02/2015
Grant date:
03/01/2018
EP Publication Date:
04/01/2017
PCT Publication Date:
03/09/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/01/2018
EP B1 Publication Date:
03/01/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/02/2018
Expiration date:
19/02/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/12/2017
 
 

Name:
Eli Lilly and Company
Address:
Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

Name:
CHAN, Edward Michael
Address:
United States (US)

Priority

Priority Number:
201461944811 P
Priority Date:
26/02/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/506; A61K 39/395; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
201801
Publication date:
03/01/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages